Systematic regional lymph node dissection for upper tract urothelial carcinoma improves patient survival

被引:10
|
作者
Furuse, Hiroshi [1 ]
Matsushita, Yuto [1 ]
Yajima, Takashi [1 ]
Kato, Taiki [1 ]
Suzuki, Takahisa [1 ]
Matsumoto, Rikiya [1 ]
Motoyama, Daisuke [1 ]
Sugiyama, Takayuki [1 ]
Otsuka, Atsushi [1 ]
Ozono, Seiichiro [1 ]
机构
[1] Hamamatsu Univ Sch Med, Dept Urol, Hamamatsu, Shizuoka, Japan
关键词
kidney pelvis; ureter; urogenital neoplasms; lymph node dissection; survival; UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; POSITIVE BLADDER-CANCER; RADICAL CYSTECTOMY; PROGNOSTIC-FACTORS; LYMPHADENECTOMY; IMPACT; NEPHROURETERECTOMY; MULTICENTER; TUMORS;
D O I
10.1093/jjco/hyw179
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Unlike for bladder cancer, the impact of regional lymph node dissection for upper tract urothelial carcinoma is unclear. We explored whether patient survival was influenced by systematic regional lymph node dissection, using resection templates according to the main tumor location, during radical nephroureterectomy for upper tract urothelial carcinoma. Methods: The systematic regional lymph node dissection group was defined as cases in which the dissection of nodes and surrounding tissues followed the established template, and the nonsystematic regional lymph node dissection group as cases undergoing limited or no lymph node dissection. We performed radical nephroureterectomy on 98 consecutive patients with various stages of upper tract urothelial carcinoma from May 1994 to September 2014 at our institution. Of these, 77 patients with cTanyN0M0 of upper tract urothelial carcinoma undergoing radical nephroureterectomy were grouped into systematic regional lymph node dissection or non-systematic regional lymph node dissection cohorts according to the extent of dissection, and their outcomes compared. Results: Forty-four patients were categorized as systematic regional lymph node dissection and 33 as non-systematic regional lymph node dissection, including 17 with more limited nodal dissection and 16 with no nodal dissection. Five-year recurrence-free survival and cancer-specific survival were significantly higher in the systematic regional lymph node dissection (93% and 94%, respectively) than in the non-systematic regional lymph node dissection group (75% and 77% recurrence-free survival and cancer-specific survival, respectively). Further, 5-year recurrence-free survival and cancer-specific survival of muscle-invasive upper tract urothelial carcinoma (pT2-4) were significantly higher in the systematic regional lymph node dissection (87% and 91%, respectively) than in the non-systematic regional lymph node dissection group (59% and 62%, respectively) (P = 0.0237 and P = 0.0224). Neither recurrence-free survival nor cancer-specific survival was significantly prolonged by systematic dissection in patients with pTis-1 histology. Conclusions: Systematic regional lymph node dissection during radical nephroureterectomy for cTanyN0M0 upper tract urothelial carcinoma patients has a significantly beneficial impact on survival compared with patients undergoing more limited dissection, especially in the cases involving muscle invasion.
引用
收藏
页码:239 / 246
页数:8
相关论文
共 50 条
  • [21] Current trends in site-specific lymph node dissection for upper tract urothelial carcinoma: precise staging and survival
    Jia, Yige
    Wu, Kan
    Li, Xiang
    INTERNATIONAL JOURNAL OF SURGERY, 2025, 111 (01) : 1677 - 1679
  • [22] Impact of Lymph Node Dissection on Cancer Specific Survival in Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy
    Roscigno, Marco
    Shariat, Shahrokh F.
    Margulis, Vitaly
    Karakiewicz, Pierre
    Remzi, Mesut
    Kikuchi, Eiji
    Langner, Cord
    Lotan, Yair
    Weizer, Alon
    Bensalah, Karim
    Raman, Jay D.
    Bolenz, Christian
    Guo, Charles C.
    Wood, Christopher G.
    Zigeuner, Richard
    Wheat, Jeffrey
    Kabbani, Wareef
    Koppie, Theresa M.
    Ng, Casey K.
    Suardi, Nazareno
    Bertini, Roberto
    Fernandez, Mario I.
    Mikami, Shuji
    Isida, Masaru
    Michel, Maurice Stephan
    Montorsi, Francesco
    JOURNAL OF UROLOGY, 2009, 181 (06): : 2482 - 2489
  • [24] Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023
    Yanagisawa, Takafumi
    Kawada, Tatsushi
    von Deimling, Markus
    Laukhtina, Ekaterina
    Kimura, Takahiro
    Shariat, Shahrokh F.
    CURRENT OPINION IN UROLOGY, 2023, 33 (04) : 258 - 268
  • [25] Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma
    Seisen, Thomas
    Shariat, Shahrokh F.
    Cussenot, Olivier
    Peyronnet, Benoit
    Renard-Penna, Raphaele
    Colin, Pierre
    Roupret, Morgan
    WORLD JOURNAL OF UROLOGY, 2017, 35 (04) : 535 - 548
  • [26] Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma
    Thomas Seisen
    Shahrokh F. Shariat
    Olivier Cussenot
    Benoit Peyronnet
    Raphaële Renard-Penna
    Pierre Colin
    Morgan Rouprêt
    World Journal of Urology, 2017, 35 : 535 - 548
  • [27] A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma REPLY
    Lughezzani, Giovanni
    Budaus, Lars
    Sun, Maxine
    Karakiewicz, Pierre I.
    UROLOGY, 2010, 75 (01) : 125 - 125
  • [28] Comparative study of lymph node dissection, and oncological outcomes of laparoscopic and open radical nephroureterectomy for patients with urothelial carcinoma of the upper urinary tract undergoing regional lymph node dissection
    Abe, Takashige
    Kondo, Tsunenori
    Harabayashi, Toru
    Takada, Norikata
    Matsumoto, Ryuji
    Osawa, Takahiro
    Minami, Keita
    Nagamori, Satoshi
    Maruyama, Satoru
    Murai, Sachiyo
    Tanabe, Kazunari
    Shinohara, Nobuo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (11) : 1001 - 1011
  • [29] Utility of lymph node dissection for clinical node negative upper tract urothelial cell carcinoma: A multicenter study
    Hamilton, Zachary
    Haifler, Miki
    Krabbe, Laura-Maria
    Clinton, Timothy N.
    Han, Daniel
    Ryan, Stephen
    Reddy, Madhumitha
    Field, Charles
    Bloch, Aaron
    Wan, Fang
    Uzzo, Robert
    Margulis, Vitaly
    Derweesh, Ithaar
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [30] UTILITY OF LYMPH NODE DISSECTION FOR CLINICAL NODE NEGATIVE UPPER TRACT UROTHELIAL CELL CARCINOMA: A MULTICENTER STUDY
    Hamilton, Zachary
    Haifler, Miki
    Krabbe, Laura-Maria
    Clinton, Timothy
    Han, Daniel
    Ryan, Stephen
    Reddy, Madhumitha
    Field, Charles
    Bloch, Aaron
    Uzzo, Robert
    Margulis, Vitaly
    Derweesh, Ithaar
    JOURNAL OF UROLOGY, 2018, 199 (04): : E160 - E160